AEON Biopharma

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell AEON Biopharma and other ETFs, options, and stocks.

About AEON

AEON Biopharma, Inc. is a biopharmaceutical company, which engages in the business of developing proprietary botulinum toxin complex, ABP-450 injection, for debilitating medical conditions. The company was founded by Robert E. 

CEO
Robert E. Bancroft
CEORobert E. Bancroft
Employees
8
Employees8
Headquarters
Irvine, California
HeadquartersIrvine, California
Founded
2012
Founded2012
Employees
8
Employees8

AEON Key Statistics

Market cap
12.81M
Market cap12.81M
Price-Earnings ratio
-0.07
Price-Earnings ratio-0.07
Dividend yield
Dividend yield
Average volume
1.06M
Average volume1.06M
High today
$0.3022
High today$0.3022
Low today
$0.283
Low today$0.283
Open price
$0.2985
Open price$0.2985
Volume
240.00K
Volume240.00K
52 Week high
$1.45
52 Week high$1.45
52 Week low
$0.2222
52 Week low$0.2222

Stock Snapshot

The current AEON Biopharma(AEON) stock price is $0.29, with a market capitalization of 12.81M. The stock trades at a price-to-earnings (P/E) ratio of -0.07.

On 2026-08-05, AEON Biopharma(AEON) stock traded between a low of $0.28 and a high of $0.30. Shares are currently priced at $0.29, which is +2.5% above the low and -4.0% below the high.

The AEON Biopharma(AEON)'s current trading volume is 240K, compared to an average daily volume of 1.06M.

In the last year, AEON Biopharma(AEON) shares hit a 52-week high of $1.45 and a 52-week low of $0.22.

In the last year, AEON Biopharma(AEON) shares hit a 52-week high of $1.45 and a 52-week low of $0.22.

AEON News

TipRanks 2d
AEON Biopharma Regains NYSE American Listing Compliance

Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions Subscribe to TipRanks Smart Investor Newsletter, and...

TipRanks 7d
Lake Street starts Aeon Biopharma at Buy on potential of Botox competitor

As previously reported, Lake Street initiated coverage of Aeon Biopharma (AEON) with a Buy rating and $1 price target Aeon is developing a biosimilar that has t...

TipRanks 7d
Aeon Biopharma initiated with a Buy at Lake Street

Lake Street initiated coverage of Aeon Biopharma (AEON) with a Buy rating and $1 price target Published first on TheFly – the ultimate source for real-time, ma...

People also own

Based on the portfolios of people who own AEON. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.